In today’s competitive and evidence-driven healthcare landscape, demonstrating the value of your therapy is essential—not just to regulators, but to payers, providers, and patients. Our integrated Value, Access, and HEOR services help pharmaceutical, biotech, and medtech companies navigate complex global markets, accelerate access, and optimize outcomes.
Value, Access, and HEOR
Expertise to Support Your Value, Access, and HEOR Needs
Work with our team of experts to help you define and communicate the value of your product from early development through launch and beyond. Whether you're introducing a novel product, expanding into new markets, or refining your value story, we’re here to help.
Health Economics
RTI-HS delivers health economics consulting solutions to demonstrate product value, support HTA submissions, and inform market access decisions.
Health Economics Services
As one of the most experienced and respected health economics consulting and research organizations, we can provide strategic advice and help you choose and implement the right methodology to answer your research questions. We also provide innovative methods to uncover hidden subpopulations or differential responders in your data that can lead to new opportunities for your product.
Decision-Analytic Models
Decision-analytic models provide a framework for compiling clinical and economic evidence in a systematic fashion, determining your product’s value, and communicating that value to decision makers.
Database Studies
Leverage databases for health economic and pharmacoepidemiology research, enhancing safety assessments, and treatment effectiveness studies
Utility Assessment
Measure patient preferences for health outcomes to generate utility scores for use in your economic models to inform decisions on healthcare resource allocation and product value
Literature Reviews
Synthesize existing scientific findings to help you evaluate current knowledge, identify gaps, and inform development decisions
Meta-Analysis
Use rigorous, state-of-the-art methodologies to quantitatively synthesize evidence from literature reviews and enable reliable insights for healthcare decision-making
ICER Support
Proactively protect value, optimize pricing, and ensure your therapy aligns with ICER’s evolving landscape
Workshop / Training
Invest in learning that delivers lasting impact with our blend of expert insights and practical tools to help your team thrive in a continually evolving landscape.
Delphi Panels
Delphi panels can help you gain actionable insight without requiring the lengthy timeline of some traditional studies.
Retrospective Chart Reviews
Retrospective chart reviews use real-world data to help you better understand drivers that could influence your product strategy.
Cross-Sectional Surveys
Capture current disease prevalence, treatment modalities, and risk factors to enrich your real-world evidence for dossiers and support regulatory applications
Longitudinal Surveys
Leverage the power of longitudinal studes to understand changes in health, treatment response, and real-world outcomes over time
Statistical Analysis
Data analysis and visualization that can help strengthen your pharma or medical technology product development
Causal Inference
Apply the target trial emulation framework to tackle challenges of analyzing RWD
Clinical Trial Data Analysis
Unlock the full potential of your clinical trial data by transforming complex datasets into clear, compelling insights that drive regulatory success and market access
Site-Based Studies
Combine the rigor of in-person clinical assessments with deep patient insights gathered through structured surveys
External Control Arm Analysis
Use real-world evidence to efficiently and credibly evaluate novel treatments
Value and Access
You need the right strategies and tactics to reflect your product’s value and gain market access. And when millions—or maybe billions—are on the line, you have to be confident that your healthcare market access strategies are well researched and that your tactics reflect real-world context. We can partner with you to deliver the research quality and integrated thinking your drug, diagnostic, or device needs to achieve optimal market access. Our experience spans all major therapeutic areas and phases of development.
Value and Access Services
At every stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s value. For clinical and commercial teams alike, we provide extensive research experience, industry and regulatory knowledge, and evidence-based tools to help commercialize your product.
Value Communication Materials
Ensure your research findings and value messages can be adopted by relevant audiences with high-impact communication tools
Expert Perspective Research
Navigate the complexities of pricing, reimbursement, and access to ensure your product meets the expectations of decision-makers worldwide
Global Value Dossiers
Comprehensive, evidence-based deliverables that communicate the clinical, humanistic, and economic value of your product to diverse stakeholders
AMCP Dossiers
Standardized AMCP dossiers present evidence of your product’s value to support formulary decisions by U.S. healthcare payers
Delphi Panels
Delphi panels can help you gain actionable insight without requiring the lengthy timeline of some traditional studies.
Literature Reviews
Synthesize existing scientific findings to help you evaluate current knowledge, identify gaps, and inform development decisions
HTA Submissions
Strategic and technical expertise to help you develop and submit high-quality health technology assessment (HTA) and reimbursement dossiers for global market access.
HTA and Reimbursement Submissions
RTI Health Solutions helps you develop HTA and reimbursement submissions that demonstrate value, meet payer needs, and support market access.
HTA and Reimbursement Submission Services
We can support pharmaceutical and medtech companies with comprehensive HTA and reimbursement submission services to help you navigate complex global market access requirements, offering strategic guidance, technical expertise, and full-spectrum support across clinical, economic, and regulatory domains.
HTA Submissions
Strategic and technical expertise to help you develop and submit high-quality health technology assessment (HTA) and reimbursement dossiers for global market access.
AMCP Dossiers
Standardized AMCP dossiers present evidence of your product’s value to support formulary decisions by U.S. healthcare payers
Global Value Dossiers
Comprehensive, evidence-based deliverables that communicate the clinical, humanistic, and economic value of your product to diverse stakeholders
Decision-Analytic Models
Decision-analytic models provide a framework for compiling clinical and economic evidence in a systematic fashion, determining your product’s value, and communicating that value to decision makers.
Literature Reviews
Synthesize existing scientific findings to help you evaluate current knowledge, identify gaps, and inform development decisions
Utility Assessment
Measure patient preferences for health outcomes to generate utility scores for use in your economic models to inform decisions on healthcare resource allocation and product value
Health Equity
Bridge equity and innovation across the pharmaceutical lifecycle
ICER Support
Proactively protect value, optimize pricing, and ensure your therapy aligns with ICER’s evolving landscape
Expert Perspective Research
Navigate the complexities of pricing, reimbursement, and access to ensure your product meets the expectations of decision-makers worldwide
Value Communication Materials
Ensure your research findings and value messages can be adopted by relevant audiences with high-impact communication tools
Outcomes Research
Beyond the evidence standards set by traditional clinical trials, well-designed and implemented outcomes research can help you, your patients, regulators, and prescribers understand the real-world use, value, and safety of your products. Observational studies are also increasingly important for reimbursement decisions in both the US and many European countries as risks and benefits, patient-centricity, and comparative effectiveness continue to be the driving themes within the industry.
Outcomes Research Services
See how we can help you gain critical insights into the real-world effectiveness, safety, and value of your products.
Cross-Sectional Surveys
Capture current disease prevalence, treatment modalities, and risk factors to enrich your real-world evidence for dossiers and support regulatory applications
Longitudinal Surveys
Leverage the power of longitudinal studes to understand changes in health, treatment response, and real-world outcomes over time
Site-Based Studies
Combine the rigor of in-person clinical assessments with deep patient insights gathered through structured surveys
AMCP Dossiers
Standardized AMCP dossiers present evidence of your product’s value to support formulary decisions by U.S. healthcare payers